Beta2-Microglobulin as a Diagnostic Marker in Cerebrospinal Fluid: A Follow-Up Study

Table 4

CSF Beta2-microglobulin—result of post hoc multiple comparisons of diagnostic subgroups.

Compared groups	Level of Significance
Bacterial meningitis/encephalitis—Control group	𝑃<0.0001
Bacterial meningitis/encephalitis—Viral meningitis/encephalitis	𝑃<0.0001
Bacterial meningitis/encephaliti—Polyneuritis/polyneuropathies	𝑃<0.0001
Bacterial meningitis/encephalitis—Neuroborreliosis	𝑃<0.0001
Bacterial meningitis/encephalitis—Scavenger reaction	𝑃<0.0001
Bacterial meningitis/encephalitis—Multiple sclerosis	𝑃<0.0001
Bacterial meningitis/encephalitis—Brain tumours/Malignant infiltrations	𝑃=0.0066
Brain tumours/Malignant infiltrations—Control group	𝑃<0.0001
Brain tumours/Malignant infiltrations—Multiple sclerosis	𝑃<0.0001
Brain tumours/Malignant infiltrations—Polyneuritis/polyneuropathies	𝑃<0.0001
Viral meningitis/encephalitis—Control group	𝑃<0.0001
Viral meningitis/encephalitis—Multiple sclerosis	𝑃<0.0001
Viral meningitis/encephalitis—Polyneuritis/polyneuropathies	𝑃<0.0001
Neuroborreliosis—Control group	𝑃<0.0001
Neuroborreliosis—Multiple sclerosis	𝑃<0.0001
Neuroborreliosis—Polyneuritis/polyneuropathies	𝑃<0.0001
Scavenger reaction—Control group	𝑃<0.0001
Scavenger reaction—Multiple sclerosis	𝑃<0.0001
Scavenger reaction—Polyneuritis/polyneuropathies	𝑃<0.0001
Multiple sclerosis—Control group	𝑃<0.0001
Multiple sclerosis—Polyneuritis/polyneuropathies	𝑃<0.0001
Other groups	No difference